About Respiratory Syncytial Virus (RSV) Postfusion Glycoprotein F Recombinant Protein

Respiratory Syncytial Virus (RSV) is an enveloped, negative-sense single-stranded RNA virus belonging to the genus Orthopneumovirus in the family Pneumoviridae. The Fusion (F) glycoprotein is the major viral surface protein responsible for membrane fusion and viral entry. During infection, the F protein undergoes an irreversible conformational transition from the metastable prefusion (Pre-F) state to the stable postfusion (Post-F) state. The postfusion conformation retains several conserved antigenic epitopes and is widely used in studies of RSV biology, antibody characterization, diagnostic assay development, and vaccine research.

eEnzyme's RSV Postfusion Glycoprotein F Recombinant Protein is produced for research use and is suitable for antibody screening, ELISA development, Western blotting, epitope mapping, structural characterization, and RSV vaccine research. This recombinant protein provides a valuable reagent for investigating RSV fusion mechanisms, immune responses, and antiviral therapeutic development.

Applications

Biological Significance of RSV Postfusion Glycoprotein F

The postfusion conformation of the RSV F protein represents the stable end state following membrane fusion and contains several conserved epitopes recognized by neutralizing antibodies, including clinically important antibodies such as palivizumab. Together with the prefusion F protein, the postfusion antigen is widely used to investigate antibody specificity, antigenic structure, immune responses, and RSV vaccine design. The RSV Postfusion Glycoprotein F Recombinant Protein provides a valuable research tool for studies of RSV biology, immunology, and the development of diagnostics and next-generation therapeutics.